📊 BLNC Key Takeaways
Investment Thesis
Balance Labs is a distressed company with catastrophic financial deterioration, negative stockholders' equity of -$8.7M, and severe operational losses that far exceed its minimal revenue base. The company is burning cash at an unsustainable rate with virtually no liquidity ($4.5K cash) and liabilities exceeding assets by nearly 165x, indicating imminent insolvency risk.
BLNC Strengths
- Minimal debt service obligations relative to asset base may allow brief operational runway
- Company remains publicly reporting, enabling potential restructuring communication
- Long-term debt of $525K is manageable in absolute terms if revenue can recover significantly
BLNC Risks
- Negative stockholders' equity of -$8.7M indicates technical insolvency and potential equity elimination
- Revenue collapsed 60.4% YoY to only $247.5K while losing $3.7M, demonstrating complete business model failure
- Critically low liquidity with current ratio of 0.01x and cash reserves of only $4.5K; company cannot fund operations beyond days
- Operating cash flow is deeply negative at -$93.5K with negative free cash flow of -$103K, indicating no self-sustaining business
- Net margin of -1514% and operating margin of -149% represent fundamental unprofitability at scale
- Zero insider activity in last 90 days suggests loss of management confidence or operational paralysis
Key Metrics to Watch
- Quarterly revenue trend - any further decline below $247.5K indicates terminal business deterioration
- Cash burn rate and remaining cash runway - currently unsustainable and approaching zero liquidity event
- Stockholders' equity trajectory - need to monitor if negative equity worsens or if restructuring occurs
- Operating cash flow - must show dramatic improvement toward positive territory to indicate viable operations
- Insider transactions and management changes - may signal restructuring or liquidation plans
BLNC Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BLNC Profitability Ratios
BLNC vs Default Sector
How Balance Labs, Inc. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BLNC Balance Sheet & Liquidity
BLNC 5-Year Financial Trend
5-Year Trend Summary: Balance Labs, Inc.'s revenue has grown significantly by 3,612% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.02 indicates the company is currently unprofitable.
BLNC Growth Metrics (YoY)
BLNC Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2023 | $67.5K | -$68.7K | $0.00 |
| Q2 2023 | $67.5K | -$96.8K | $0.00 |
| Q1 2023 | $67.5K | -$87.3K | $0.00 |
| Q3 2022 | $67.5K | -$142.6K | $0.00 |
| Q2 2022 | $67.5K | -$182.5K | $-0.01 |
| Q1 2022 | $67.5K | -$181.4K | $-0.01 |
| Q3 2021 | $200.0K | -$269.1K | $-0.01 |
| Q3 2020 | $3.3K | -$252.2K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BLNC Capital Allocation
BLNC SEC Filings
Access official SEC EDGAR filings for Balance Labs, Inc. (CIK: 0001632121)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BLNC
What is the AI rating for BLNC?
Balance Labs, Inc. (BLNC) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BLNC's key strengths?
Minimal debt service obligations relative to asset base may allow brief operational runway. Company remains publicly reporting, enabling potential restructuring communication.
What are the risks of investing in BLNC?
Negative stockholders' equity of -$8.7M indicates technical insolvency and potential equity elimination. Revenue collapsed 60.4% YoY to only $247.5K while losing $3.7M, demonstrating complete business model failure.
What is BLNC's revenue and growth?
Balance Labs, Inc. reported revenue of $247.5K.
Does BLNC pay dividends?
Balance Labs, Inc. does not currently pay dividends.
Where can I find BLNC SEC filings?
Official SEC filings for Balance Labs, Inc. (CIK: 0001632121) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BLNC's EPS?
Balance Labs, Inc. has a diluted EPS of $-0.17.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.